Vimarsana
Biggest News Aggregation in the World

Page 4 - Emergent Biosolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emergent Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emergent Biosolution Today - Breaking & Trending Today

Over-the-counter Narcan hitting shelves in September - Vimarsana News

Over-the-counter Narcan hitting shelves in September

Emergent’s name-brand Narcan was FDA-approved in March, and was the first-ever naloxone product to be approved for use without a prescription in the U.S.

Opioid OD Rescue Drug Narcan Will Reach Drug Store Shelves Next Week - Vimarsana News

Opioid OD Rescue Drug Narcan Will Reach Drug Store Shelves Next Week

WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.

Over-the-counter Narcan to hit drugstore shelves next week - Vimarsana News

Over-the-counter Narcan to hit drugstore shelves next week

Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.

Source: yahoo.com
Over-the-counter Narcan to hit drugstore shelves next week - Vimarsana News

Over-the-counter Narcan to hit drugstore shelves next week

Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.

Source: upi.com
Reviewing Emergent BioSolutions (NYSE:EBS) and Hepion Pharmaceuticals (NASDAQ:HEPA) - Vimarsana News

Reviewing Emergent BioSolutions (NYSE:EBS) and Hepion Pharmaceuticals (NASDAQ:HEPA)

Hepion Pharmaceuticals (NASDAQ:HEPA – Get Free Report) and Emergent BioSolutions (NYSE:EBS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Analyst Recommendations This is a summary of […]

Source: wkrb13.com